TRIB3 and cancer: PFS is an important indicator of the quality of life of malignant tumor patients; it was revealed that the PFS in the high TRIB3 expression cohort was significantly shorter than low TRIB3 expression cohort (Figure 4C), indicating that TRIB3 is an important marker affecting the prognosis and HNSC disease progression, and TRIB3 might be a potential prognostic factor.